Stephens Inc Enovis Corp Transaction History

Stephens Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$55.44 - $63.8 $69,521 - $80,005	-1,254 Reduced 16.26%	6,458 $403,000
Q4 2023 Feb 13, 2024	SELL	$43.67 - $57.07 $299,445 - $391,328	-6,857 Reduced 47.07%	7,712 $432,000
Q3 2023 Nov 14, 2023	SELL	$51.65 - $65.54 $623,415 - $791,067	-12,070 Reduced 45.31%	14,569 $768,000
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $657,221 - $799,640	-12,471 Reduced 31.89%	26,639 $1.71 Million
Q1 2023 May 15, 2023	SELL	$49.5 - $65.92 $166,617 - $221,886	-3,366 Reduced 7.92%	39,110 $2.09 Million
Q4 2022 Jan 25, 2023	SELL	$44.83 - $57.43 $1.17 Million - $1.5 Million	-26,035 Reduced 38.0%	42,476 $2.27 Million
Q3 2022 Nov 02, 2022	BUY	$46.07 - $60.1 $180,179 - $235,051	3,911 Added 6.05%	68,511 $3.16 Million
Q2 2022 Aug 03, 2022	BUY	$55.0 - $70.47 $3.55 Million - $4.55 Million	64,600 New	64,600 $3.55 Million

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.